Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- These days, we're overwhelmed with data. Every chart on every patient is packed full of data -- some of it incredibly useful and important, some of it just a lot of noise, some of it just copy-and-pasted and brought forward...
Read full article →(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapy targeting complement component 5 (C5), met both its primary and a key secondary endpoint in the phase III NIMBLE trial of generalized myasthenia gravis, whether...
Read full article →(MedPage Today) -- SAN DIEGO -- Clearance of circulating tumor (ct)DNA after neoadjuvant therapy correlated significantly with pathologic complete response (pCR) and distant metastasis in triple-negative breast cancer (TNBC), according to a study...
Read full article →(MedPage Today) -- Surging interest in the purported benefits of psychedelic drugs has given rise to books, documentaries, and conferences dedicated to the mind-altering substances. Now add one more business to the list: psychedelic retreats....
Read full article →Patients can take advantage of the GLP-1 management program through their One Medical primary care clinician. Medications are available for quick delivery to all 50 states, with nearly 3,000 cities having same-day delivery available.
Read full article →HHS Secretary Robert F. Kennedy Jr. went in front of the Senate Committee on Health, Education Labor and Pensions, his latest in a string of congressional hearings.
Read full article →Elevance Health is raising its guidance for 2026 even as its Q1 profits declined year-over-year.
Read full article →Same-store admissions and adjusted admissions respectively declined 1.3% and 0.5% year over year. Executives pointed to cross-market dropoffs among patients with high-deductible and managed care plans.
Read full article →Fierce Senior Writer Paige Minemyer speaks with Catherine Anderson of UnitedHealth Group about why the insurer is expanding doula support nationwide and what that could mean for maternal and infant health outcomes across the U.S.
Read full article →The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers.
Read full article →Courier Health raised $50 million in series B funding to scale its AI-powered platform purpose-built for biopharma that manages the end-to-end patient journey.
Read full article →Amperos Health CEO and co-founder Michal Miernowski told Fierce Healthcare the newly announced funding will support scaling the organization and its platform.
Read full article →